Sophrosyne Capital’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-22,300
Closed -$438K 85
2014
Q1
$438K Buy
+22,300
New +$438K 0.38% 48